EC approves AstraZeneca’s acalabrutinib combo for CLL
The approval is based on outcomes from the pivotal Phase III AMPLIFY trial.
The European Market Access Lag: 2021–2024
RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals
ADHD drugs back in the spotlight after study debunks rising prevalence
‘Dupixent-fuelled’ atopic dermatitis market sales to hit $22.4bn by 2033
EC authorises Sydnexis’ paediatric myopia treatment
Analysis
View More
Themes
View MoreJuvenescence enhances AI drug discovery with Ro5 acquisition
The platform enables evaluation of drug targets based on therapeutic, biological and market potential.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?
Recursion axes drug programmes to streamline pipeline